Scientists offer a strong counter-position to the belief that cannabis causes psychosis, pointing out the difference between correlation and causation. They argue that smoke exposure from any source (including cigarettes) could explain the reported link between cannabis and psychosis.
View this review (yellow link) or download:
This paper is also stored here: http://bit.ly/2WHtDr8 inside the CED Foundation Archive
To explore related information, click keywords below:
A 2018 study showed that, for patients with schizophrenia, adding CBD to ongoing antipsychotic treatment reduced psychotic activity, as compared to placebo add-on
View this review (yellow link) or download:
This paper is also stored here: http://bit.ly/2WztI04 inside the CED Foundation Archive
To explore related information, click keywords below:
In a study of 72 psychiatric patients given CBD in capsule form, researchers found that cannabidiol successfully decreased anxiety and improved sleep over the course of three months.
View this review (yellow link) or download:
This paper is also stored here: http://bit.ly/2WDo4yV inside the CED Foundation Archive
To explore related information, click keywords:
View this review (yellow link) or download:
This paper is also stored here: http://bit.ly/2l4sexZ inside the CED Foundation Archive
To explore related information, click the keywords below:
Preferences for Medical Marijuana over Prescription Medications Among Persons Living with Chronic Conditions: Alternative, Complementary, and Tapering Uses
In a survey of 30 patients using medical cannabis for a range of illnesses, including Rheumatoid Arthritis, cancer, Hepatitis C, PTSD, and more, patients reported an array of benefits from their cannabis use. Patients successfully used cannabis as an alternative to prescription medication, as a complementary agent with traditional prescription medicines, and to gradually help halt the use of some prescription medications. Benefits described by participants included the effects of cannabis lasting longer than that of opioids, lower risk of addiction, fewer side-effects. Patients also saw their sleep, anxiety, appetite, and adverse reactions improve with the use of medical cannabis. Larger, more controlled studies may suggest cannabis more affirmatively as an alternative or complementary therapy with prescription medications.
View this review (yellow link) or download:
This paper is also stored here: http://bit.ly/2wqDDdQ inside the CED Foundation Archive
To explore related information, click keywords:
DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults
Cannabis withdrawal syndrome affects approximately 12.1% of heavy cannabis users and is characterized by symptoms such as nervousness/anxiety, hostility, sleep difficulty, and depressed mood. It has increased prevalence among those suffering from mood disorders, anxiety disorders, and personality disorders. This new data should emphasize the need for physicians to exercise caution when recommending cannabis to individuals who may end up consuming cannabis heavily, and who also suffering from mood, anxiety, or personality disorders
Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series
Preliminary findings from a study conducted on PTSD patients open a new door for cannabidiol (CBD) as a potential supplementary treatment option. CBD indirectly activates receptors linked to behavioral responses to aversive memories, a major component of the suffering involved in PTSD. The majority of participants in this review reported a decrease in the prevalence and severity of PTSD symptoms, both in the short-, and long-term. It should be taken into consideration that this study was performed with a small sample size that lacked a placebo or control group; however, this tells a familiar story to what we see in clinic. Further research will likely support cannabinoids as a legitimate treatment option for PTSD. Under the guidance of a knowledgeable Cannabis Medicine provider, PTSD patients may also consider supplementing their current treatment plan with CBD
Read more or download PDF on the CED Foundation Archive: http://bit.ly/2Kf9INN
I wonder if we should be spending as much time on flavonoids as we do on terpenes (including cannabinoids)?
There is little doubt that they play a powerful effect. Just as the minor cannabinoids tend to be overlooked by much of the general & scientific cultures… flavonoids are also largely passed-over.
This study, for example, indicates that some of the components of dark chocolate reduce the body’s production of the stress hormone, cortisol (not surprising to most who have every consumed chocolate, but… did you know that those components are also found all over nature, including inside cannabis?!)
I’ll start adding flavonoids to the list of info to start sharing!
Cannabis can be promote increased anxiety in some people. While the details are not fully understood yet, the synergistic functioning of multiple cannabis components, known as the entourage effect, is a reliable way to lessen the paranoia and anxiety that may stem from the consumption of THC. Cannabinoids and terpenes such as CBD, pinene, linalool and more have been shown to help. http://bit.ly/3102p2w
#CBD reduces anxiety levels not just in neurotypical users, but also with patients suffering from #FragileX
Individuals suffering from the neurodevelopmental disorder Fragile X Syndrome experience many symptoms mimicking those of autism, including increased anxiety. To investigate the effects of cannabidiol (CBD) on Fragile X symptom mitigation, a mouse model possessing the DNA mutations which give rise to Fragile X was treated with CBD. CBD treatment was shown to reduce anxiety in both affected and non-affected mice while preserving locomotive, social, and cognitive performance. Future studies exploring CBD as treatment for Fragile X may reveal other benefits.
